Growth Capitalist (https://growthcapitalist.com/author/moriarty/page/148/)
Subscribers to Growth Capitalist's premium research report on emerging growth company finance can download the March 18 issue now. Log in to download your copy now. Don't subscribe yet? Register or email us for a 30-day free trial.
GenVec, Inc. (GNVC) announced that it has raised $9,040,500 in a Registered Direct transaction. The common stock was sold at $3.15 per share, an approximate 7% discount to the market price ($3.37) of GNVC at deal announcement. Roth Capital Partners and H.C. Wainwright & Co. acted as agents on the transaction. The transaction is expected to close on March 18, 2014.
Microvision, Inc. (MVIS) announced that it has raised $13,890,400 in a Registered Direct transaction. The common stock was sold at $1.94 per share, an approximate 10% discount to the market price ($2.15) of MVIS at deal announcement. A series of 2,148,000 60-Month Warrants with an exercise price of $2.47 per share (14.88% premium) was issued to the investors in this transaction. Oppenheimer & Co. Inc. acted as Underwriter on the transaction.
pSivida Corporation (PSDV) announced that it has raised $6,987,000 in a Registered Direct transaction. The common stock was sold at $4.11 per share, an approximate 7% discount to the market price ($4.42) of PSDV at deal announcement. Northland Securities acted as the exclusive agent on the transaction. The investor was RA Capital Management. The transaction is expected to close on March 18, 2014.
